Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Loza

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Immunology|January 29, 2002
Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4Matthew J Loza, Stephen P Peters, James G Zangrilli, et al.
Blood|February 7, 2002
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cellsMatthew J Loza, Loris Zamai, Livio Azzoni, et al.
The Journal of Allergy and Clinical Immunology|December 25, 2007
Interactive effects of steroids and beta-agonists on accumulation of type 2 T cellsMatthew J Loza, Susan Foster, Stephen P Peters, et al.
Respiratory Research|February 4, 2012
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary diseaseMatthew J Loza, Rosemary Watt, Frédéric Baribaud, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
beta-Agonist enhances type 2 T-cell survival and accumulationMatthew J Loza, Stephen P Peters, Susan Foster, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2019
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled TrialsStefan Siebert, Kristen Sweet, Bidisha Dasgupta, et al.
Cellular Immunology|July 19, 2011
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupusMatthew J Loza, A Shane Anderson, Kenneth S O'Rourke, et al.
Respiratory Research|July 30, 2010
Asthma and gender impact accumulation of T cell subtypesMatthew J Loza, Susan Foster, Eugene R Bleecker, et al.
International Immunology|July 20, 2005
Human peripheral CD2-/lo T cells: an extrathymic population of early differentiated, developing T cellsMatthew J Loza, Patrizia Luppi, Kerstin Kiefer, et al.
Plos One|October 18, 2007
Assembly of inflammation-related genes for pathway-focused genetic analysisMatthew J Loza, Charles E McCall, Liwu Li, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|January 29, 2002
Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4Matthew J Loza, Stephen P Peters, James G Zangrilli, et al.
Blood|February 7, 2002
Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cellsMatthew J Loza, Loris Zamai, Livio Azzoni, et al.
The Journal of Allergy and Clinical Immunology|December 25, 2007
Interactive effects of steroids and beta-agonists on accumulation of type 2 T cellsMatthew J Loza, Susan Foster, Stephen P Peters, et al.
Respiratory Research|February 4, 2012
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary diseaseMatthew J Loza, Rosemary Watt, Frédéric Baribaud, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
beta-Agonist enhances type 2 T-cell survival and accumulationMatthew J Loza, Stephen P Peters, Susan Foster, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2019
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled TrialsStefan Siebert, Kristen Sweet, Bidisha Dasgupta, et al.
Cellular Immunology|July 19, 2011
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupusMatthew J Loza, A Shane Anderson, Kenneth S O'Rourke, et al.
Respiratory Research|July 30, 2010
Asthma and gender impact accumulation of T cell subtypesMatthew J Loza, Susan Foster, Eugene R Bleecker, et al.
International Immunology|July 20, 2005
Human peripheral CD2-/lo T cells: an extrathymic population of early differentiated, developing T cellsMatthew J Loza, Patrizia Luppi, Kerstin Kiefer, et al.
Plos One|October 18, 2007
Assembly of inflammation-related genes for pathway-focused genetic analysisMatthew J Loza, Charles E McCall, Liwu Li, et al.
Pageof 6